Target Name: ZNF529-AS1
NCBI ID: G101927599
Review Report on ZNF529-AS1 Target / Biomarker Content of Review Report on ZNF529-AS1 Target / Biomarker
ZNF529-AS1
Other Name(s): ZNF529 antisense RNA 1 | ZNF529 antisense RNA 1, transcript variant 1 | ZNF529-AS1 variant 1

ZNF529-AS1: A Potential Drug Target and Biomarker

The ZNF529 gene is located on chromosome 16 and encodes for the zinc finger protein ZNF529. This gene is a key regulator of neural development and has been implicated in various neurological and psychiatric disorders. ZNF529 has also been implicated in cancer progression. Therefore, targeting ZNF529 has the potential to be a new drug target and biomarker.

ZNF529 is a protein that plays a crucial role in the development and maintenance of neural stem cells. It is expressed in various tissues and cell types, including brain, spinal cord, and peripheral tissues. ZNF529 has been shown to be involved in the formation and maintenance of neural stem cells, as well as their differentiation into functional neurons.

In addition to its role in neural development, ZNF529 has also been implicated in cancer progression. Several studies have shown that ZNF529 is overexpressed in various types of cancer, including neuroblastoma, melanoma, and breast cancer. Overexpression of ZNF529 has been shown to promote the growth and survival of cancer cells, as well as their ability to migrate and invade into other tissues.

The potential drug target for ZNF529 is its role in cancer progression. By inhibiting the activity of ZNF529, it may be possible to inhibit the growth and survival of cancer cells. This could be an effective way to treat various types of cancer, including neuroblastoma, melanoma, and breast cancer.

ZNF529 has also been implicated in the development and progression of neurological and psychiatric disorders. Several studies have shown that ZNF529 is involved in the development of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. In addition, ZNF529 has also been implicated in the development of psychiatric disorders, including depression and anxiety.

The potential biomarker for ZNF529 is its involvement in the development and progression of neurological and psychiatric disorders. This is because ZNF529 has been shown to be involved in the development of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. Therefore, measuring the levels of ZNF529 in brain or peripheral tissues may be a useful biomarker for these disorders.

In conclusion, ZNF529 is a gene that has the potential to be a drug target and biomarker. Its involvement in neural development, cancer progression, and the development of neurological and psychiatric disorders makes it an attractive target for further research. Further studies are needed to determine the full role of ZNF529 and its potential as a drug target and biomarker.

Protein Name: ZNF529 Antisense RNA 1

The "ZNF529-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF529-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646